Rallybio • RLYB
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Stephen Uden,M.B.$78.8M
Market Cap • 09/05/20242020
(há 4 anos)
2021
(3 years ago)
NASDAQ
Listagem
New Haven
Sede • Connecticut41
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RLYBSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.